FDA approves ORLADEYO from BIOCRYST PHARMACEUTICALS, INC FDA Approval Dec. 12, 2025, 23:41 UTC Final approval of NDA #NDA #219776 for BEROTRALSTAT. Decision date: 12/11/2025 Full text
There are no comments here yet...